{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-102065","form_type":"8-K","ticker":"RXST","cik":"0001111485","company_name":"RxSight, Inc.","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.367384+00:00","generated_at":"2026-05-17T21:21:39.158441+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"RxSight appoints former Axonics CEO Raymond Cohen to board of directors","bullets":["Raymond W. Cohen, former CEO of Axonics (sold to BSX for $3.7B), appointed to RxSight board as Class I director effective July 31, 2025.","Cohen also led SoniVie sale to Boston Scientific for $600M; has over 40 years medtech experience.","Will serve until 2028 annual meeting; receives standard non-employee director compensation including $277,500 initial RSU grant.","Press release issued August 4, 2025; no other changes to board or management."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-102065","json":"https://secwatch.observer/filing/0000950170-25-102065.json","markdown":"https://secwatch.observer/filing/0000950170-25-102065.md","text":"https://secwatch.observer/filing/0000950170-25-102065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025102065/0000950170-25-102065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025102065/rxst-20250731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:21:39.158441+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}